Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

New findings presented at ASH indicated that GLP-1 agonists led to a significant reduction in the risk for dangerous blood ...

The agency is due to make a determination on the shortage status of Zepbound by Dec. 19. But another delay could be possible ...

Taiwan says China sending largest naval fleet in years to region The Saudi Arabia diabetes drug market is a vital segment of the pharmaceutical industry, catering to the needs of a significant portion ...

The company sees this as promising, stating that this patient population “typically lose(s) less weight on GLP-1 therapies ... Next to the dual mechanism of action, the antibody-peptide combination ...

For just the third time in the Connor Bedard era, the Chicago Blackhawks have scored at least six goals in a game, sending the Hawks home for the Thanksgiving with a lot more to be thankful for.

BOJ Rate Hike Won’t Derail Budgets, DPP Official Indicates Over half of economists expect BOJ’s next hike in December DPP has gained leverage over ruling coalition in passing laws ...

Lawmakers from the Democratic Progressive Party (DPP) have accused their counterparts ... budget for the next 14 years is NT$28.4 billion (US$873 million), with the budget for next year set at NT$1.9 ...

A new study published in the journal Jama estimated that more than 137 million American adults are eligible for medications like Ozempic. Access to the medication is limited, especially since ...